Covid-19 test

Photo: Telangana Today

India Reports 3,230 Covid-19 Cases, 32 Deaths In 24 Hours

In India, 3,230 new Covid-19 cases were reported, which is lowest in the past 3 months, taking the active cases tally to 42,358. On September 27, the Union Ministry of Health and Family Welfare confirmed 32 deaths and 4,255 recoveries in the past 24 hours. With this, India has 0.10% active cases rate, 98.72% recovery rate and fatality rate at 1.12%. In addition, 217.82 crore Covid-19 vaccine were administered.

Tue, 27 Sep 2022 - 12:11 PM / by Varsha Joshi

Tags: Covid-19, Indian Health Ministry, vaccine, MoHFW, updates

Courtesy: The Times of India


Photo: Telangana Today

India Active Cases At 45,281, With 5,383 New Cases

India Covid-19 active cases are under 45,281 with new 5,383 cases of coronavirus, in the past 24 hours. On September 23, the Union Ministry of Health and Family Welfare confirmed 5,383 new cases, 20 deaths and 6,424 recovery cases. In addition, the recovery rate is at 98.71%, the positive case rate is at 0.10%.. Moreover, so far 217.26 crore covid-19 doses were given to people under the nationwide vaccination drive.

Fri, 23 Sep 2022 - 02:30 PM / by Varsha Joshi

Tags: India COVID-19, vaccine, Ministry of Health & Family Welfare, covid update, Nationwide Vaccine

Adar Poonawalla

Photo: The Indian Express

SII Adar Poonawalla Speaks About Monkeypox Vaccine In India

As monkeypox cases are rising in India, the Serum Institute of India (SII) which manufactured the Covid-19 vaccine, spoke about the possibility of a monkeypox vaccine in India. SII CEO Adar Poonawalla said, "We are talking to Novovax. We really need to see whether there will be a lot of demand or whether in three to four months it fizzles out." Moreover, he ruled out manufacturing from scratch amid time issues.

Tue, 26 Jul 2022 - 05:44 PM / by Varsha Joshi

Tags: Monkeypox, vaccine, SII, Adar Poonawalla, Cases


Photo: Newsweek

EU Drug Control Agency Suggests Authorizing Use Of Smallpox Vaccine To Treat Monkeypox

The use of a smallpox vaccination to treat monkeypox was suggested for authorization on July 22 by the European Union's (EU) drug authority. Imvanex, a smallpox vaccine created by the Danish pharmaceutical company Bavarian Nordic, has been authorized in the EU since 2013 for the purpose of preventing smallpox. Due to smallpox and monkeypox viruses' similarities, it was also thought to be a viable vaccination for monkeypox.

Fri, 22 Jul 2022 - 09:00 PM / by Vidhi Jhunjhunwala

Tags: European Union, Smallpox, Monkeypox, vaccine, medicine

Courtesy: NDTV

Cervical Cancer Vaccine

Photo: Femina

Centre To India's 1st Cervical Cancer Vaccine By Year-End

The Centre intends to launch India's first Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer as part of the national vaccination campaign by end of this year. Experts anticipate that it will be included in national HPV immunization efforts and will be more affordable than current vaccinations. Cervical cancer is the second most prevalent cancer type in women of reproductive age (15-44), and the second leading cause of… read-more

Tue, 19 Jul 2022 - 03:20 PM / by Vidhi Jhunjhunwala

Tags: Cervical Cancer, vaccine, India, Cervavac, Vaccination Drive

Courtesy: DNA INDIA

(Representational Image)

Photo: Science Business

Around 18.64 Crore Unutilised Covid Vaccine Doses Available With States, UTs

The Union Ministry of Health and Family Welfare shared on 7th May that over 18.64 crore unutilised Covid vaccine doses are still available with states and Union Territories. More than 193.53 crore doses have been provided to the states and the UTs so far through the Government of India, the Union Health Ministry noted. The Covid vaccination drive had started in India on January 16, 21.

Sat, 07 May 2022 - 05:51 PM / by Varun Das

Tags: Vaccination Drive, vaccine, Covid Vaccination, Coronavirus, pandemic

Courtesy: ANI

(Representational Image)

Photo: India Today

Chandigarh Admin Puts Vaccine Mandate On Hold Following SC Order

The UT Chandigarh Administration has shelved its plans to bar unvaccinated school students from attending physical classes following the SC order, which held that vaccine mandates are not proportionate. UT Adviser Dharam Pal, who had earlier banned unvaccinated people from public places, now admits, "Covid vaccination is optional." Parents and schools have welcomed the decision that no student should be barred from education, regardless of… read-more

Wed, 04 May 2022 - 05:08 PM / by Varun Das

Tags: COVID, vaccine, Chandigarh, Supreme Court, fundamental rights

Courtesy: Hindustan Times


Photo: Hindustan Times

Delhi COVID-19 Cases Rise With 1,414 New Cases In 24 Hrs

Delhi is constantly witnessing a surge in COVID-19 cases in India. On May 4, the national capital registered 1,414 new cases, with 1,171 recoveries and one death. Furthermore, the active cases in the city are currently at 5,986 with a daily positivity rate of 5.97%. Moreover, the national capital administered COVID-19 vaccine doses to 45,853 people, taking the overall tally to 3,35,79,923 to date, asking people to follow COVID-19 protocols.… read-more

Wed, 04 May 2022 - 09:34 AM / by Varsha Joshi

Tags: Delhi, Covid-19 cases, India, vaccine, Rise

Courtesy: ANI

(Representational Image)

Photo: The Times of India

Chandigarh Admin To Bar Unvaccinated Students From Attending Classes

The UT Chandigarh Administration has decided to bar unvaccinated school students, who are eligible for vaccination, from attending physical classes. There are no options for online classes either. Notably, a sero-survey had revealed in July 2021, that 69% of the children in Chandigarh already had Covid antibodies, due to past infection. Dr Jayaprakash Muliyil, an NTAGI member, had earlier said that there was no need to vaccinate children.

Wed, 27 Apr 2022 - 04:10 PM / by Varun Das

Tags: COVID, Covid-19, vaccine, children, Chandigarh

Courtesy: The Tribune

(Representational Image)

Photo: Science Business

SII Halts COVID-19 Vaccine Production Amid Low Demand

The Serum Institute of India has halted the production of the Covishield (AstraZeneca) vaccine amid a glut of vaccine supplies. The SII's stockpile of vaccines has swelled to 200 million doses. The export of Covid vaccines had been earlier restricted, but resumed in November last year. The SII had recently appealed to the government to cut the gap between the second dose and the "precautionary" dose to just six months.

Sat, 23 Apr 2022 - 10:30 AM / by Varun Das

Tags: Covid-19, Coronavirus, COVISHIELD, Covishield vaccine, vaccine

Courtesy: The Times of India